Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A Thrombolysis in Myocardial Infarction 10B substudy

American Heart Journal

Volumn 142, Issue 1, 2001, Pages 29-36

  Srinivas, V S ^a   Cannon, Christopher P ^b   Gibson, C Michael ^c   Antman, Elliott M ^b   Greenberg, Mark A ^a   Tanasijevic, Milenko J ^b   Murphy, Sabina ^c   De Lemos, James A ^d   Sokol, Seth ^a   Braunwald, Eugene ^b   Mueller, Hiltrud S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CREATINE KINASE MB; HEPARIN; MYOGLOBIN; TENECTEPLASE; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE MARKER; FEMALE; FIBRINOLYTIC THERAPY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION;

EID: 0034961506     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.116068     Document Type: Article

References (17)

1. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
2. The prognostic value of serum troponin T in unstable angina
3. Cardiac troponin T levels for risk stratification in acute myocardial ischemia: GUSTO IIA Investigators
4. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes: The GUSTO-lla Investigators
5. Myoglobin, creatine kinase MB, and cardiac troponin-l to assess reperfusion after thrombolysis for acute myocardial infarction: Results from TIMI 10A
6. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction
7. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: Results of the TIMI 10B trial: Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators
8. Thrombolysis in Myocardial Infarction (TIMI) trial: Phase 1 findings
9. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
10. Myoglobin, creatine-kinase-MB and cardiac troponin-l 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: Results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B
11. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients. GUSTO-l Investigators
12. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction: The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators
13. ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
14. Troponin T measurement after myocardial infarction can identify left ventricular election of less than 40%
15. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum
16. Diagnostic strategies in myocardial infarction using myoglobin measurement
17. Troponin T or troponin I or CK-MB (or none?)